GemPharmatech Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 249.82 million compared to CNY 177.87 million a year ago. Revenue was CNY 250.37 million compared to CNY 178.47 million a year ago.

Net income was CNY 81.64 million compared to CNY 46.34 million a year ago. Basic earnings per share from continuing operations was CNY 0.22 compared to CNY 0.13 a year ago. Diluted earnings per share from continuing operations was CNY 0.22 compared to CNY 0.13 a year ago.